Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

H+P (Exam 4) Hypertension > Pulmonary Arterial Hypertension > Flashcards

Pulmonary Arterial Hypertension Flashcards

1
Q

What is the formula for Pulmonary Vascular Resistance?

A

PVR=(mPAP - PAWP)/ CO

.schmidt…

31

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What procedure is done to diagnose, classify and devlop treatment for Pulmonary Artery HTN?

A

Right Heart Catheterization

31

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mPAP can be increased by what four mechanisms?

A
  1. Elevated resistance to blood flow within arterial circulation
  2. Increased pulmonary venous pressure from Left heart disease
  3. Chronically increased pulmonary blood flow
  4. A combination of these processes

31

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PH can result from abnormalities in the __________________ or ________________ components of the lung circulation, sometimes includes contributions from ____________.

A

PH can result from abnormalities in the arterial or venous components of the lung circulation, sometimes includes contributions from both

31

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

After Right heart catheterization the severity of the PH can be determined to be:
Mild PH (mPAP = ________________)
Moderate PH (mPAP = ____________)
Severe PH (mPAP= ________________)

A

Mild PH (mPAP = 20-30mmHg)
Moderate PH (mPAP = 31-40mmHg)
Severe PH (mPAP= >40mmHg)

32

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which diagnostic test or screening tool can be done to estimate pulmonary arterial systolic pressure (PSAP)?

A

Echocardiogram

32

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Can a echocardiographic Pulmonary arterial systolic pressure of >41mmHg provide a definitive diagnosis for Pulmonary Hypertention?

A

**No

Although echocardiographic
PASP > 41 mmHg is relatively sensitive and specific for PH,* it cannot provide the accurate mPAP for definitive diagnosis*

32

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How much volume can a normal Pulmonary circulation accomodate without a marked change in mean pulmonary artery pressure (mPAP)?

A

Normal pulmonary circulation can accommodate a fourfold increase in COP without a marked change in mPAP

32

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What three things can a TTE reveal to help diagnose Pulmonary Artery HTN?

A
  1. RA enlargement
  2. RV enlargement
  3. Elevated Peak tricuspid-regurgitation

32

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

According to the World Health Organization, PAH is classified as a __________ disease. It affects ________ people per million per year

A

According to the World Health Organization, PAH is classified as a rare disease effecting15 ppl per million per year

33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Does idopathic PAH have any identifiable risk factors?

A

NOPE

33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What medication has shown long-term improvements in 1 in 8 patients with PAH?

A

Calcium channel blockers

33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What percent of patients have the inherited genetic protein mutation (BMPR2) that can cause PAH?

What is BMPR2?

A

3% of PAH cases are deemed inheritable.

BMPR2 - bone morphogenetic protein receptor type 2

33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Remaining cases of PAH that are not genetic mutations are caused by:
a. drugs
b. toxins
c. various diseases
d. all of the above

A

d. all the above

The remaining cases are designated “associated PAH,” since they can be ascribed to manifestations of drugs, toxins, or other diseases

33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Current data shows PAH develops in this age range and population.

A

Current data shows a demographic shift, now with older pts and more men being diagnosed

PAH was traditionally a disease of young women, with median survival rate of 3 yrs

33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Even with improved diagnosis of PAH and therapies the 1 year mortality rate is:
a. 10%
b. 15%
c. 25%
d. 5%

A

b. 15%

Despite improved diagnosis and therapy, 1-year mortality is** ̴15%**

33

17
Q

What medication has shown long-term improvements in 1 in 8 patients with PAH?

A

Calcium channel blockers

33

18
Q

What PAH treatment mimics the effect of prostacyclin to produce vasodilation while inhibiting platelet aggregation.

A

Prostanoids!

35

19
Q

What are the four examples of Prostanoids medications and their routes of administration?

A

epoprostenol (IV)
iloprost (inhaled)
treprostinil (SQ, IV, INH, PO)
beraprost(PO)
*

35

20
Q

Which Prostanoid medication has been PROVEN to reduce mortality?

A

Epoprostenol IV

35

21
Q

What is the MOA of Postanoids, when using it to treat pulmonary artery hypertenision?

A
  • mimic the effect of prostacyclin to produce vasodilation while inhibiting platelet aggregation.
  • They also have anti-inflammatory effects and may reduce proliferation of vascular smooth muscle cells

slide 36

22
Q

How does Endothilin Receptor antagonists (ERAs) improve pulmonary arterial hypertenion

A

hemodynamics and exercise capacity

The vascular endothelial dysfunction associated with PAH involves an imbalance between vasodilating (nitric oxide) and vasoconstricting (endothelin) substances. ERAs have been shown to improve hemodynamics and exercise capacity

Slide 37

23
Q

How does nitric oxide/ guanylate cycase improve pulmonary arterial hypertenion?

A

nitric oxide produces pulmonary vasodilation by stimulating guanylate cyclase and cGMP formation in smooth muscle cells.
*
This effect is transient because nitric oxide is quickly bound by hgb and degraded by phosphodiesterase type 5*

Slide 37

24
Q

What are the areas that nitric oxide has been widely used?

A

perioperative
critical care
preparpations for home

slide 37

25
Q

True or False: Chronic therapy has been directed toward PD-5 inhibitors

A

True

Slide 37

26
Q

What are the nonspecific signs of pulmonary arterial hypertension for preop consideration?

A
  • fatigue
  • dyspnea
  • cough

Slide 38

27
Q

What consideration should be given to pulmonary arterial hypertension procedure with pre-op?

A
  • venous embolism
  • elevations in venous and/or airway
  • pressure hypoxic pulmonary

Slide 38

28
Q

What are the more advance signs to take in consideration for preop for patients with pulmonary arterial hypertnsion?

A

**angina and syncope **

occur with exercise if coronary blood flow cannot meet demand of a hypertrophied RV

Slide 38

29
Q

Patient with pulmonary arterial hypertension may exhibit____ on physical exam

list

A
  • parasternal lift
  • accentuated S2, S3 and/or s4 gallop
  • JVD
  • peripheral edema
  • hepatomegaly
  • ascites

Slide 38

30
Q

PAH Preop Considerations

What is recommended prior to mod-high risk surgery in pts with mod-severe PH?

A

Right Heart Cath

S39

31
Q

PAH Preop Considerations

  • Due to potential discrepancies btw PAWP and LVEDP, a _____ _____ ____ is done with coexisting left heart dz bc may lead to ____ of PH
  • Vasoreactivity testing, often with inhaled _____ ______ , during right heart cath to determine responsiveness to ______ therapy
    o __-__ % PAH pts are nonresponsive to inhaled nitric oxide, but those that are responsive also respond to ____ ***
A
  • left heart cath
  • misclassification
  • nitric oxide
  • vasodilator
  • 85-90%
  • CCB’s

S39

H+P (Exam 4) Hypertension (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions